Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

Sheffield United CEO Stephen Bettis has questioned the likelihood of any instant impact the Independent Football Regulator may be able to have on the ongoing crisis at Sheffield Wednesday. The Owls ...

The Writers Guild of America East is telling its CBS News members that the network assured them that they won’t face discipline if they decline to respond to new editor-in-chief Bari Weiss’ memo to ...

“I hope you are as excited as I am about the prospect of elevating CBS News to its rightful place as No. 1: the most trusted and most consumed news source in the nation,” Weiss wrote. “So, I’m ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

DCN member data, which echoes Pew Research, shows what Google won’t admit: AI overviews siphon attention, erode publisher traffic, and harm the open web’s promise of discovery. The numbers are in – ...

U.S. Sens. Jeff Merkley and Elizabeth Warren, Ranking Member of the Senate Banking, Housing, and Urban Affairs Committee, Chris Van Hollen, Mazie Hirono, and Bernie Sanders have sent a letter to ...